Literature DB >> 25849761

Functional characterization of CYP107W1 from Streptomyces avermitilis and biosynthesis of macrolide oligomycin A.

Songhee Han1, Tan-Viet Pham1, Joo-Hwan Kim1, Young-Ran Lim1, Hyoung-Goo Park1, Gun-Su Cha2, Chul-Ho Yun2, Young-Jin Chun3, Lin-Woo Kang4, Donghak Kim5.   

Abstract

Streptomyces avermitilis contains 33 cytochrome P450 genes in its genome, many of which play important roles in the biosynthesis process of antimicrobial agents. Here, we characterized the biochemical function and structure of CYP107W1 from S. avermitilis, which is responsible for the 12-hydroxylation reaction of oligomycin C. CYP107W1 was expressed and purified from Escherichia coli. Purified proteins exhibited the typical CO-binding spectrum of P450. Interaction of oligomycin C and oligomycin A (12-hydroxylated oligomycin C) with purified CYP107W1 resulted in a type I binding with Kd values of 14.4 ± 0.7 μM and 2.0 ± 0.1 μM, respectively. LC-mass spectrometry analysis showed that CYP107W1 produced oligomycin A by regioselectively hydroxylating C12 of oligomycin C. Steady-state kinetic analysis yielded a kcat value of 0.2 min(-1) and a Km value of 18 μM. The crystal structure of CYP107W1 was determined at 2.1 Å resolution. The overall P450 folding conformations are well conserved, and the open access binding pocket for the large macrolide oligomycin C was observed above the distal side of heme. This study of CYP107W1 can help a better understanding of clinically important P450 enzymes as well as their optimization and engineering for synthesizing novel antibacterial agents and other pharmaceutically important compounds.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CYP; CYP107W1; Oligomycin; P450; Streptomyces avermitilis; X-ray crystal structure

Mesh:

Substances:

Year:  2015        PMID: 25849761     DOI: 10.1016/j.abb.2015.03.025

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

Review 1.  Cytochromes P450 for natural product biosynthesis in Streptomyces: sequence, structure, and function.

Authors:  Jeffrey D Rudolf; Chin-Yuan Chang; Ming Ma; Ben Shen
Journal:  Nat Prod Rep       Date:  2017-08-30       Impact factor: 13.423

Review 2.  Recent Structural Insights into Cytochrome P450 Function.

Authors:  F Peter Guengerich; Michael R Waterman; Martin Egli
Journal:  Trends Pharmacol Sci       Date:  2016-06-04       Impact factor: 14.819

3.  Biochemical and Structural Characterization of MycCI, a Versatile P450 Biocatalyst from the Mycinamicin Biosynthetic Pathway.

Authors:  Matthew D DeMars; Fang Sheng; Sung Ryeol Park; Andrew N Lowell; Larissa M Podust; David H Sherman
Journal:  ACS Chem Biol       Date:  2016-08-05       Impact factor: 5.100

4.  More P450s Are Involved in Secondary Metabolite Biosynthesis in Streptomyces Compared to Bacillus, Cyanobacteria, and Mycobacterium.

Authors:  Fanele Cabangile Mnguni; Tiara Padayachee; Wanping Chen; Dominik Gront; Jae-Hyuk Yu; David R Nelson; Khajamohiddin Syed
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

5.  Characterization of high-H2O2-tolerant bacterial cytochrome P450 CYP105D18: insights into papaverine N-oxidation.

Authors:  Bashu Dev Pardhe; Hackwon Do; Chang-Sook Jeong; Ki-Hwa Kim; Jun Hyuck Lee; Tae-Jin Oh
Journal:  IUCrJ       Date:  2021-06-29       Impact factor: 4.769

6.  Structural Analysis of the Streptomyces avermitilis CYP107W1-Oligomycin A Complex and Role of the Tryptophan 178 Residue.

Authors:  Songhee Han; Tan-Viet Pham; Joo-Hwan Kim; Young-Ran Lim; Hyoung-Goo Park; Gun-Su Cha; Chul-Ho Yun; Young-Jin Chun; Lin-Woo Kang; Donghak Kim
Journal:  Mol Cells       Date:  2016-02-16       Impact factor: 5.034

7.  Characterization of a Biflaviolin Synthase CYP158A3 from Streptomyces avermitilis and Its Role in the Biosynthesis of Secondary Metabolites.

Authors:  Young-Ran Lim; Songhee Han; Joo-Hwan Kim; Hyoung-Goo Park; Ga-Young Lee; Thien-Kim Le; Chul-Ho Yun; Donghak Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.